V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160008433 | 160019326 | 1.78 | 59 | Palliative (P) | 2019-01-12 | 2019-12-18 | GEMCITABINE | 02 | N | GEMCITABINE | 100659790 |
| 160008630 | 160019327 | 1.8 | 153.7 | null | 2022-02-28 | 2022-03-07 | CISPLATIN + ETOPOSIDE + PACLITAXEL | 02 | null | OLAPARIB | 100288187 |
| 160008800 | 160019328 | null | 75 | null | 2017-11-04 | 2017-11-06 | GemCarbo Days 1+8 | 02 | null | NB HRNBL-1 BUMEL MAT | 100275941 |
| 160008933 | 160019329 | 1.62 | 135 | Palliative (P) | 2017-08-03 | 2017-08-03 | STS Rhabdomyosarcoma RMS 2005 IVADo | 02 | N | PEMETREXED | 101078869 |
| 160009395 | 160019330 | 1.62 | 24.6 | Curative (C) | 2020-03-22 | 2020-05-09 | Doxorubicin + Ifosfamide | 01 | N | EW EUROEWING 2012 ARM A VIDE | 100169012 |
| 160009742 | 160019331 | 0 | 71.6 | Palliative (P) | 2017-12-18 | 2018-05-06 | VINCRISTINE | 02 | N | ETOPOSIDE + IFOSFAMIDE | 101683016 |
| 160009800 | 160019332 | null | 59.6 | Curative (C) | 2016-11-16 | 2016-12-19 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100706611 |
| 160010360 | 160019333 | 1.58 | 68.9 | null | 2018-05-20 | 2018-06-04 | Cisplatin + Etoposide po | 02 | null | OLAPARIB | 100726315 |
| 160010408 | 160019334 | 1.67 | 77.3 | null | 2017-09-08 | 2017-09-09 | NB HRNBL-1 COJEC Ind COURSE B | 01 | null | CARBOPLATIN + VINORELBINE | 101861151 |
| 160010801 | 160019336 | 1.74 | 75 | Curative (C) | 2017-03-21 | 2017-08-03 | EW Rel rEECur Gemcitabine/Docetaxel | 02 | N | CYCLOPHOSPHAMIDE | 100508709 |
| 160010938 | 160019337 | 1.58 | 60.8 | Curative (C) | 2019-04-24 | 2019-08-15 | STS Rhabdo RMS 2005 Vin Cyclo | 01 | N | ETOPOSIDE | 101163903 |
| 160011377 | 160019338 | 0 | 69 | null | 2020-12-27 | 2021-01-12 | Cyclophosphamide + Vincristine | 01 | null | EW EUROEWING 2012 ARM B VC | 100726833 |
| 160011895 | 160019339 | 1.65 | 12.7 | Curative (C) | 2020-07-28 | 2020-08-30 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | TRIAL | 101049355 |
| 160012366 | 160019340 | 1.54 | 77.1 | Palliative (P) | 2018-02-15 | 2018-02-28 | VAI (Ifos 3g/m2) | 01 | N | FLUOROURACIL + OXALIPLATIN | 100358644 |
| 160012860 | 160019341 | 1.62 | 57 | Curative (C) | 2020-07-04 | 2020-08-18 | Irinotecan + Temozolomide | 02 | N | CYCLOPHOSPHAMIDE | 100453526 |
| 160013237 | 160019342 | 1.79 | 18.6 | null | 2019-02-01 | 2019-02-01 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | null | GEMCITABINE | 100446913 |
| 160013461 | 160019343 | null | 85.7 | null | 2019-10-26 | 2019-11-10 | DACTINOMYCIN + CYCLO + VINCRISTINE | 01 | null | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 101452805 |
| 160013479 | 160019344 | 1.77 | 80.85 | Palliative (P) | 2019-11-05 | 2021-04-17 | GEMCITABINE | 02 | N | NB RELAPSED CYCLOPHOSPHAMIDE AND TOPOTECAN | 100037693 |
| 160014131 | 160019345 | 1.3 | 68.6 | null | 2019-08-22 | 2019-08-22 | NEMO TRIAL | null | null | IFOSFAMIDE | 101216764 |
| 160014432 | 160019346 | 1.61 | 63.9 | null | 2020-03-09 | 2020-03-23 | STS Rhabdomyosarcoma RMS 2005 IVA | null | null | ERIBULIN | 101285374 |
| 160014891 | 160019347 | 1.61 | 73.4 | Curative (C) | null | 2018-02-01 | NB HRNBL-1 COJEC Ind COURSE B | 02 | N | CISPLATIN + VINORELBINE | 101812067 |
| 160015510 | 160019348 | null | 98 | Palliative (P) | 2022-05-29 | 2022-05-30 | Cyclophosphamide PO +Vinorelbine IV | 02 | N | IFOSFAMIDE | 101243872 |
| 160015547 | 160019349 | 1.61 | 67.6 | Palliative (P) | 2018-08-06 | 2018-12-27 | null | 02 | N | IVA | 101260596 |
| 160016067 | 160019350 | 0 | 73.6 | Palliative (P) | 2022-02-10 | 2022-03-15 | GEMCITABINE | 02 | N | IFOSFAMIDE | 100042257 |
| 160016294 | 160019351 | 1.67 | 82.3 | null | 2018-12-23 | 2018-12-26 | null | 02 | null | CARBOPLATIN + LIPOSOMAL DOX | 100012257 |
| 160016351 | 160019352 | 1.56 | 51 | Neo-adjuvant (N) | 2017-06-19 | 2017-07-03 | OCTOPUS Trial | 02 | N | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100433377 |
| 160017106 | 160019355 | 1.76 | 82.3 | Curative (C) | 2019-03-05 | 2019-03-14 | CHOP R - 21 days | N | Y | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 100451101 |
| 160017345 | 160019356 | 1.67 | 59.1 | Palliative (P) | 2016-10-11 | 2017-07-27 | ETOP 13-18 BEAT-meso Trial | 02 | N | PEMETREXED | 101752473 |
| 160017512 | 160019357 | 1.14 | 129.9 | 03 | 2019-01-23 | 2019-02-27 | PEMBROLIZUMAB | 02 | N | CAPECITABINE + MITOMYCIN | 101539516 |
| 160007409 | 160019358 | 1.85 | 17.2 | Curative (C) | 2019-11-14 | 2019-11-15 | Olaratumab | 02 | N | CYCLOPHOSPHAMIDE | 101332352 |
| 160012676 | 160019360 | 0 | 116.5 | Palliative (P) | 2019-12-24 | 2020-01-18 | CARBOPLATIN + VINORELBINE | 01 | N | DACARBAZINE + GEMCITABINE | 101571023 |
| 160014160 | 160019362 | 1.83 | 59.6 | Curative (C) | 2021-07-07 | 2021-07-11 | Cyclophosphamide oral | N | N | IDELALISIB | 101205055 |
| 160010915 | 160019500 | null | null | null | null | 2018-11-23 | null | null | null | CARBOPLATIN + PEMETREXED | 101225284 |
| 160010930 | 160019502 | null | null | null | 2020-07-10 | 2020-07-11 | null | null | null | CARBOPLATIN + PEMETREXED | 101179990 |
| 160011132 | 160019506 | null | null | null | null | 2021-05-24 | null | null | null | CARBOPLATIN + PEMETREXED | 100466360 |
| 160011219 | 160019508 | null | null | null | null | 2021-05-19 | null | 02 | null | CARBOPLATIN + PEMETREXED | 101378075 |
| 160011385 | 160019514 | 1.9 | 92.2 | Palliative (P) | null | 2021-01-14 | Carboplatin + Pemetrexed | null | N | CARBOPLATIN + PEMETREXED | 100886000 |
| 160011485 | 160019519 | null | null | null | 2021-04-03 | 2021-04-24 | null | 2 | null | CARBOPLATIN + PEMETREXED | 100908986 |
| 160011638 | 160019525 | null | null | null | null | 2021-01-26 | null | null | null | CARBOPLATIN + PEMETREXED | 101162460 |
| 160011646 | 160019526 | null | null | null | null | null | null | 02 | null | CARBOPLATIN + PEMETREXED | 101720413 |
| 160011689 | 160019527 | 1.79 | null | null | null | 2016-09-02 | null | null | null | CARBOPLATIN + PEMETREXED | 101790619 |
| 160011798 | 160019528 | null | null | null | 2018-12-22 | 2018-12-24 | null | null | null | CARBOPLATIN + PEMETREXED | 101828336 |
| 160011841 | 160019530 | null | null | null | null | 2017-09-08 | null | null | null | CARBOPLATIN + PEMETREXED | 100953140 |
| 160011995 | 160019535 | null | 102.5 | Palliative (P) | 2022-01-04 | 2022-01-13 | Carboplatin + Pemetrexed | 2 | N | CARBOPLATIN + PEMETREXED | 100136868 |
| 160012104 | 160019540 | 1.76 | null | null | 2020-11-20 | 2020-12-02 | Carboplatin + Pemetrexed | 02 | null | CARBOPLATIN + PEMETREXED | 101420529 |
| 160012141 | 160019542 | 1.77 | null | null | null | null | null | 02 | null | CARBOPLATIN + PEMETREXED | 100677858 |
| 160012393 | 160019549 | 1.67 | 64.45 | null | 2019-05-17 | 2019-06-19 | Carboplatin + Pemetrexed | 02 | null | CARBOPLATIN + PEMETREXED | 100027831 |
| 160012427 | 160019552 | 1.69 | 78.8 | Palliative (P) | 2021-10-21 | 2021-10-25 | Carboplatin + Pemetrexed | null | N | CARBOPLATIN + PEMETREXED | 101683542 |
| 160012488 | 160019558 | null | 69.9 | 03 | null | 2022-03-24 | Carboplatin + Pemetrexed | null | N | CARBOPLATIN + PEMETREXED | 101056923 |
| 160012577 | 160019563 | 1.57 | 76.6 | null | 2022-05-27 | 2022-05-27 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 101100314 |